Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections (Q28236279)

Expert Opinion on Pharmacotherapy

Europe PubMed Central

title

Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections (English)

0 references

author name string

Andrew Hemphill

series ordinal

1

0 references

Joachim Mueller

series ordinal

2

0 references

Marco Esposito

series ordinal

3

0 references

language of work or name

English

0 references

publication date

May 2006

0 references

published in

0 references

volume

7

0 references

issue

7

0 references

page(s)

953-64

0 references

cites work

Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses

1 reference

https://api.crossref.org/works/10.1517/14656566.7.7.953

Treatment of intestinal parasitic infections: a review of nitazoxanide

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Nitazoxanide: a new thiazolide antiparasitic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Nitazoxanide: a new broad spectrum antiparasitic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Successful treatment of human fascioliasis with nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Effect of Nitazoxanide in Persistent Diarrhea and Enteritis Associated With

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Use of nitazoxanide as a new therapeutic option for persistent diarrhea: a pediatric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

The plasma membrane of microaerophilic protists: oxidative and nitrosative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Flowcytometric assessment of the effect of drugs on Giardia lamblia trophozoites in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Systemic acquired resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953

Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.953